{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:22:25Z","timestamp":1794576145143,"version":"4.9.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jcyt.2026.102897","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:09:13Z","timestamp":1776668953000},"page":"102897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The evolving role of umbilical cord blood in transplantation, immunotherapy, and regenerative medicine: a brief contemporary review by the ISCT lab practices committee"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1041-4931","authenticated-orcid":false,"given":"Rajdeep","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4719-4629","authenticated-orcid":false,"given":"Elena","family":"Maryamchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Holovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Morato-Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhat","family":"Askar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3113-9155","authenticated-orcid":false,"given":"Nadim","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4890-1900","authenticated-orcid":false,"given":"Wanxing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette C.","family":"Tanhehco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph (Yossi)","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2026.102897_bib0001","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM198910263211707","article-title":"Hematopoietic reconstitution in a patient with Fanconi\u2019s anemia by means of umbilical-cord blood from an HLA-identical sibling","volume":"321","author":"Gluckman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.103042","article-title":"Umbilical cord blood hematopoietic cells: from biology to hematopoietic transplants and cellular therapies","volume":"55","author":"Mayani","year":"2024","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jcyt.2026.102897_bib0003","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102897_bib0004","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41409-025-02694-z","article-title":"Real-world graft utilization after CTN-1101: a registry-based analysis of haploidentical graft versus umbilical cord blood trends","volume":"60","author":"Tran","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102897_bib0005","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/bloodadvances.2021004462","article-title":"Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning","volume":"5","author":"Wagner","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2026.102897_bib0006","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","article-title":"Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities","volume":"16","author":"Barker","year":"2010","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102897_bib0007","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200006223422501","article-title":"Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and international bone marrow transplant registry working committee on alternative donor and stem cell sources","volume":"342","author":"Rocha","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0008","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.bbmt.2017.08.004","volume":"23","author":"Pagliuca","year":"2017","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102897_bib0009","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3390\/jcm8111968","article-title":"Clinical relevance of immunobiology in umbilical cord blood transplantation","volume":"8","author":"Yun","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0010","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1182\/blood-2014-07-589176","article-title":"The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation","volume":"124","author":"Politikos","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102897_bib0011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2010.07.009","article-title":"Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance","volume":"79","author":"Kim","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0012","article-title":"Umbilical cord blood derived cellular therapy: advances in clinical development","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0013","doi-asserted-by":"crossref","first-page":"eadf3120","DOI":"10.1126\/sciadv.adf3120","article-title":"Cord blood-derived V\u03b42+ and V\u03b42- T cells acquire differential cell state compositions upon in vitro expansion","volume":"9","author":"Ng","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.jcyt.2026.102897_bib0014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fimmu.2017.00329","article-title":"Umbilical cord blood natural killer cells, their characteristics, and potential clinical applications","volume":"8","author":"Sarvaria","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/stcltm\/szac086","article-title":"Umbilical cord blood transplantation: connecting its origin to its future","volume":"12","author":"Sanchez-Petitto","year":"2023","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0016","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102897_bib0017","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/scd.2009.0327","article-title":"Biological differences between neonatal and adult human hematopoietic stem\/progenitor cells","volume":"19","author":"Mayani","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2026.102897_bib0018","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood-2003-09-3079","article-title":"Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication","volume":"103","author":"Gammaitoni","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102897_bib0019","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183607","article-title":"Restoring mitochondrial function promotes hematopoietic reconstitution from cord blood following cryopreservation-related functional decline","volume":"135","author":"Huang","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2026.102897_bib0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/scd.2010.0263","article-title":"Stromal-derived factor-1\/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow","volume":"20","author":"Sharma","year":"2011","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2026.102897_bib0021","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/stcltm\/szac056","article-title":"Clinical progress and preclinical insights into umbilical cord blood transplantation improvement","volume":"11","author":"Sun","year":"2022","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0022","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.stem.2020.12.002","article-title":"UM171 preserves epigenetic marks that are reduced in ex vivo culture of human HSCs via potentiation of the CLR3-KBTBD4 complex","volume":"28","author":"Chagraoui","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2026.102897_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.570282","article-title":"Umbilical cord blood transplants: current status and evolving therapies","volume":"8","author":"Gupta","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jcyt.2026.102897_bib0024","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/blood.2021011719","article-title":"Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study","volume":"138","author":"Horwitz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102897_bib0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41467-024-55225-7","article-title":"Deciphering the effect of UM171 on human hematopoietic progenitor cell fate through clonal analysis","volume":"16","author":"Coulombe","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2026.102897_bib0026","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1182\/bloodadvances.2023010599","article-title":"Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence","volume":"7","author":"Cohen","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2026.102897_bib0027","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s12015-020-09981-w","article-title":"Mechanistic basis of ex vivo umbilical cord blood stem progenitor cell expansion","volume":"16","author":"Sica","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jcyt.2026.102897_bib0028","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41556-025-01814-7","article-title":"Inhibiting ferroptosis enhances ex vivo expansion of human haematopoietic stem cells","volume":"27","author":"Della Volpe","year":"2025","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0029","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/HS9.0000000000000285","article-title":"Double umbilical cord blood transplantation in high-risk hematological patients: a phase II study focusing on the mechanism of graft predominance","volume":"3","author":"Kalin","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.jcyt.2026.102897_bib0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3324\/haematol.2013.092254","article-title":"Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France","volume":"99","author":"Labopin","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2026.102897_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/20406207221076762","article-title":"Durable outcomes of double cord blood transplantation in adults with acute lymphoblastic leukemia: high-risk features for early and long-term mortality","volume":"13","author":"Yoon","year":"2022","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107517","article-title":"Single vs double umbilical cord blood transplantation in acute leukemia: systematic review and meta-analysis","volume":"142","author":"Odutola","year":"2024","journal-title":"Leuk Res"},{"key":"10.1016\/j.jcyt.2026.102897_bib0033","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1405584","article-title":"One-unit versus two-unit cord-blood transplantation for hematologic cancers","volume":"371","author":"Wagner","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1561174","article-title":"New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies","volume":"16","author":"Rassek","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105833","article-title":"Umbilical cord blood immune cell profiles in relation to the infant gut microbiome","volume":"26","author":"Moroishi","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.jcyt.2026.102897_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2283353","article-title":"g-NK cells from umbilical cord blood are phenotypically and functionally different than g-NK cells from peripheral blood","volume":"12","author":"Gao","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2026.102897_bib0037","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.3390\/cancers14184439","article-title":"Cord blood-derived natural killer cell exploitation in immunotherapy protocols: more than a promise?","volume":"14","author":"Damele","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jcyt.2026.102897_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584099","article-title":"Cord-blood natural killer cell-based immunotherapy for cancer","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0039","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13045-022-01382-5","article-title":"Natural killer cells in clinical development as non-engineered, engineered, and combination therapies","volume":"15","author":"Lamers-Kok","year":"2022","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0040","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0041","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0042","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0043","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0044","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fimmu.2020.00611","article-title":"Human regulatory T cells from umbilical cord blood display increased repertoire diversity and lineage stability relative to adult peripheral blood","volume":"11","author":"Motwani","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13098-024-01277-0","article-title":"Multiply restimulated human cord blood-derived Tregs maintain stabilized phenotype and suppressive function and predict their therapeutic effects on autoimmune diabetes","volume":"16","author":"Bi","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jcyt.2026.102897_bib0046","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102897_bib0047","doi-asserted-by":"crossref","first-page":"35611","DOI":"10.18632\/oncotarget.26242","article-title":"Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution","volume":"9","author":"Kellner","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcyt.2026.102897_bib0048","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.jcyt.2026.102897_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166135","article-title":"Opportunities for Treg cell therapy for the treatment of human disease","volume":"14","author":"Bluestone","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4285\/ctr.25.0040","article-title":"Regulatory T cell therapy in solid organ transplantation: clinical applications and laboratory monitoring strategies","volume":"39","author":"Nam","year":"2025","journal-title":"Clin Transplant Res"},{"key":"10.1016\/j.jcyt.2026.102897_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1626085","article-title":"Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapy","volume":"16","author":"Pikor","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0052","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.jcyt.2026.102897_bib0053","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0054","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","article-title":"Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells","volume":"36","author":"Miyao","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2026.102897_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8529104","article-title":"Expansion of gammadelta T cells from cord blood: a therapeutical possibility","volume":"2018","author":"Berglund","year":"2018","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2026.102897_bib0056","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/vaccines11020406","article-title":"In vitro expansion of V\u03b41+ T cells from cord blood by using artificial antigen-presenting cells and anti-CD3 antibody","volume":"11","author":"Hur","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.jcyt.2026.102897_bib0057","doi-asserted-by":"crossref","first-page":"334","DOI":"10.37349\/ei.2022.00054","article-title":"Allogeneic gamma delta T cells as adoptive cellular therapy for hematologic malignancies","volume":"2","author":"Jhita","year":"2022","journal-title":"Explor Immunol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0058","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/cells9081757","article-title":"Engineering the bridge between innate and adaptive immunity for cancer immunotherapy: focus on \u03b3\u03b4 T and NK cells","volume":"9","author":"Morandi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2026.102897_bib0059","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007981","article-title":"Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies","volume":"12","author":"Rao","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jcyt.2026.102897_bib0060","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/2326-6066.CIR-23-0189","article-title":"A bispecific \u03b3\u03b4 T-cell engager targeting EGFR activates a potent V\u03b39V\u03b42 T cell-mediated immune response against EGFR-expressing tumors","volume":"11","author":"King","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jcyt.2026.102897_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.834002","article-title":"CRISPR gene editing of human primary NK and T cells for cancer immunotherapy","volume":"12","author":"Elmas","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0062","article-title":"The CCR5 gene edited CD34+CD90+ hematopoietic stem cell population serves as an optimal graft source for HIV","volume":"13","author":"Karuppusamy","year":"2022","journal-title":"Gene Therapy. Front Immunol."},{"key":"10.1016\/j.jcyt.2026.102897_bib0063","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2017.226","article-title":"Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity","volume":"32","author":"Liu","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2026.102897_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1586912","article-title":"Closed-system manufacturing of therapeutic NK cells using automated cell enrichment and concentration processes enables scalable, robust and cost-effective solutions","volume":"13","author":"Kok","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0065","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3548917","article-title":"The immunomodulatory potential of Wharton\u2019s jelly mesenchymal stem\/stromal cells","volume":"2019","author":"Vieira Paladino","year":"2019","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2026.102897_bib0066","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.3390\/cells10123278","article-title":"Mesenchymal stem\/stromal cells derived from human and animal perinatal tissues-origins, characteristics, signaling pathways, and clinical trials","volume":"10","author":"Kulus","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2026.102897_bib0067","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13287-021-02158-3","article-title":"The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases","volume":"12","author":"Yang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2026.102897_bib0068","article-title":"An overview of current research on mesenchymal stem cell-derived extracellular vesicles: a bibliometric analysis from 2009 to 2021","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0069","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/sctm.17-0102","article-title":"Effect of autologous cord blood infusion on motor function and brain connectivity in young children with cerebral palsy: a randomized, placebo-controlled trial","volume":"6","author":"Sun","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0070","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/sctm.20-0470","article-title":"Sibling umbilical cord blood infusion is safe in young children with cerebral palsy","volume":"10","author":"Sun","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0071","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/1574888X18666221201114756","article-title":"Stem cell treatment and cerebral palsy: a systematic review and meta-analysis","volume":"19","author":"Motavaf","year":"2024","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2026.102897_bib0072","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3390\/ijms20102433","article-title":"Autologous cord blood in children with cerebral palsy: a review","volume":"20","author":"Boruczkowski","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcyt.2026.102897_bib0073","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/sctm.16-0474","article-title":"Autologous cord blood infusions are safe and feasible in young children with autism spectrum disorder: results of a single-center phase i open-label trial","volume":"6","author":"Dawson","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0074","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpeds.2020.03.011","article-title":"A phase II randomized clinical trial of the safety and efficacy of intravenous umbilical cord blood infusion for treatment of children with autism spectrum disorder","volume":"222","author":"Dawson","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcyt.2026.102897_bib0075","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1021\/acsabm.0c00831","article-title":"Mesenchymal stem cell-derived exosomes for treatment of autism spectrum disorder","volume":"3","author":"Liang","year":"2020","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.jcyt.2026.102897_bib0076","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","article-title":"Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy","volume":"164","author":"Cotten","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcyt.2026.102897_bib0077","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1038\/s41598-020-61311-9","article-title":"Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety","volume":"10","author":"Tsuji","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2026.102897_bib0078","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/stcltm\/szad027","article-title":"A pilot phase I trial of allogeneic umbilical cord tissue-derived mesenchymal stromal cells in neonates with hypoxic-ischemic encephalopathy","volume":"12","author":"Cotten","year":"2023","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0079","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fphys.2019.00282","article-title":"Mesenchymal stromal cell derived extracellular vesicles reduce hypoxia-ischaemia induced perinatal brain injury","volume":"10","author":"Sisa","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13287-021-02222-y","article-title":"Human umbilical cord-derived mesenchymal stem\/stromal cells: a promising candidate for the development of advanced therapy medicinal products","volume":"12","author":"Mebarki","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2026.102897_bib0081","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/sctm.18-0031","article-title":"Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: a phase ia clinical trial","volume":"7","author":"Park","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0082","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9534574","article-title":"Exosomes secreted by umbilical cord blood-derived mesenchymal stem cell attenuate diabetes in mice","volume":"2021","author":"Sharma","year":"2021","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jcyt.2026.102897_bib0083","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/4775285","article-title":"Effects of extracellular vesicles derived from human umbilical cord blood mesenchymal stem cells on cell immunity in nonobese mice","volume":"2024","author":"Ou","year":"2024","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2026.102897_bib0084","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3748\/wjg.v22.i26.6036","article-title":"Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats","volume":"22","author":"Chai","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s11033-024-09664-6","article-title":"Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis","volume":"51","author":"Shi","year":"2024","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jcyt.2026.102897_bib0086","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/mt.2011.202","article-title":"N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction","volume":"20","author":"Lee","year":"2012","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"10.1016\/j.jcyt.2026.102897_bib0087","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049447","article-title":"Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo","volume":"7","author":"Roura","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jcyt.2026.102897_bib0088","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1634\/stemcells.2005-0365","article-title":"Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger\u2019s disease and ischemic limb disease animal model","volume":"24","author":"Kim","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2026.102897_bib0089","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/sj.mt.6300302","article-title":"Umbilical cord blood-derived progenitor cells enhance muscle regeneration in mouse hindlimb ischemia model","volume":"15","author":"Koponen","year":"2007","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"10.1016\/j.jcyt.2026.102897_bib0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.diabres.2012.09.034","article-title":"Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action","volume":"98","author":"Park","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcyt.2026.102897_bib0091","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.transproceed.2012.03.044","article-title":"Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury","volume":"44","author":"Park","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcyt.2026.102897_bib0092","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/bjh.17468","article-title":"The wider perspective: cord blood banks and their future prospects","volume":"195","author":"Querol","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2026.102897_bib0093","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.hemonc.2020.04.001","article-title":"Targeted recruitment of optimal donors for unrelated hematopoietic cell transplantation: the stem cell club process","volume":"13","author":"Fingrut","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jcyt.2026.102897_bib0094","doi-asserted-by":"crossref","first-page":"E537","DOI":"10.1503\/cmaj.109-3885","article-title":"National cord blood bank to recruit ethnic donors aggressively","volume":"183","author":"Eggertson","year":"2011","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"key":"10.1016\/j.jcyt.2026.102897_bib0095","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jcyt.2022.03.012","article-title":"Ethnic diversity and cord blood banking: satisfying the unmet need","volume":"24","author":"Wynn","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102897_bib0096","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jcyt.2022.06.002","article-title":"A comprehensive human leukocyte antigen analysis of 36 782 cord blood units stored in the Australian Public Cord Blood Banking Network","volume":"24","author":"Klamer","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102897_bib0097","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/09674845.2007.11732779","article-title":"Optimising methods of red cell sedimentation from cord blood to maximise nucleated cell recovery prior to cryopreservation","volume":"64","author":"Madkaikar","year":"2007","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.jcyt.2026.102897_bib0098","first-page":"405","article-title":"Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study","volume":"11","author":"Solves","year":"2013","journal-title":"Blood Transfus Trasfus Sangue"},{"key":"10.1016\/j.jcyt.2026.102897_bib0099","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/146532401317248036","article-title":"A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences","volume":"3","author":"Alonso","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102897_bib0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2174\/157488810793351703","article-title":"Volume reduction in routine cord blood banking","volume":"5","author":"Solves","year":"2010","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2026.102897_bib0101","first-page":"41","article-title":"Advancements in umbilical cord biobanking: a comprehensive review of current trends and future prospects","volume":"17","author":"AlOraibi","year":"2024","journal-title":"Stem Cells Cloning Adv Appl"},{"key":"10.1016\/j.jcyt.2026.102897_bib0102","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1017\/gheg.2018.6","article-title":"Strategies for screening cord blood for a public cord blood bank in high HIV prevalence regions","volume":"3","author":"Meissner-Roloff","year":"2018","journal-title":"Glob Health Epidemiol Genomics"},{"key":"10.1016\/j.jcyt.2026.102897_bib0103","first-page":"324","article-title":"An update on methods for cryopreservation and thawing of hemopoietic stem cells","volume":"54","author":"Lecchi","year":"2016","journal-title":"Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"key":"10.1016\/j.jcyt.2026.102897_bib0104","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/jcm10020293","article-title":"High integrity and fidelity of long-term cryopreserved umbilical cord blood for transplantation","volume":"10","author":"Kim","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcyt.2026.102897_bib0105","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1232281","article-title":"Immunology of cord blood T-cells favors augmented disease response during clinical pediatric stem cell transplantation for acute leukemia","volume":"11","author":"Borrill","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jcyt.2026.102897_bib0106","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3390\/cells8111401","article-title":"Perinatal mesenchymal stromal cells and their possible contribution to fetal-maternal tolerance","volume":"8","author":"Magatti","year":"2019","journal-title":"Cells"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:23:17Z","timestamp":1794572597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926008583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":106,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1465324926008583"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102897","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolving role of umbilical cord blood in transplantation, immunotherapy, and regenerative medicine: a brief contemporary review by the ISCT lab practices committee","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102897"}}